By Christopher Kuo

Staar Surgical shares climbed after the company swung to a first-quarter profit amid a surge in revenue.

Shares of the medical-device company rose 11% on Thursday to $32.76 after reaching a new 52-week high of $35.87 earlier in the session. The stock is up 41% year to date.

The company reported a first-quarter profit of $5.21 million, or 10 cents a share, compared with a loss of $54.2 million, or $1.10 a share, a year earlier. Analysts polled by FactSet expected a loss of 5 cents a share.

Sales more than doubled to $93.5 million. Analysts expected $78.7 million. The growth in sales was driven by strong performance in China, including a successful launch of its implantable contact lens for nearsightedness and astigmatism, Staar said. The company also reported double-digit growth in the Americas. In the U.S., sales growth reflected increased surgeon adoption and improved commercial execution, the company said.

Staar said its operating expenses fell to $60.9 million from $85.4 million in the prior year. The company reduced its general and administrative expenses and its selling and marketing expenses, it said.

Write to Christopher Kuo at chris.kuo@wsj.com

(END) Dow Jones Newswires

May 14, 2026 12:55 ET (16:55 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.